Evidence map›Paper›PMID 42170519›Full record

ReviewDrug design, development and therapy2026

Comprehensive Review on the Toxicity of Five Main AQ Constituents from Rhubarb: Mechanisms, Challenges and Future Perspectives.

Linyuan Yu, Yongxian Jiang, Ping Li, Jun Wang, Peng Tang, Yongli Zhao

Abstract readReview
In one paragraph

Review in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Linyuan YuDepartment of Pharmacy, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, 610095, People's Republic of China.
Yongxian JiangDepartment of Pharmacy, Sichuan Provincial Maternity and Child Health Care Hospital, Chengdu, Sichuan, 610041, People's Republic of China.
Ping LiDepartment of Pharmacy, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, 610095, People's Republic of China.
Jun WangDepartment of Pharmacy, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, 610095, People's Republic of China.
Peng TangDepartment of Pharmacy, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, 610095, People's Republic of China.
Yongli ZhaoDepartment of Pharmacy, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, 610095, People's Republic of China.ORCID 0009-0002-3432-7194

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Emodin, rhein, aloe-emodin, physcion, and chrysophanol are five representative anthraquinones (AQs) in rhubarb. They exhibit diverse pharmacological activities, including antitumor, anti-inflammatory, antibacterial, and antioxidant effects, and are widely used in traditional Chinese medicines (TCMs), dietary supplements, and functional foods. However, with their increasing application, the potential toxicity of AQs has become increasingly prominent. Moreover, their toxic mechanisms and metabolism-related toxicities remain incompletely elucidated, which has limited their clinical development and safe application to a certain extent. Objective: This paper systematically reviews the toxicological characteristics, toxic mechanisms, and metabolism-related toxicity of the five major AQs in rhubarb, and explores research strategies for AQs toxicity based on advanced technologies, aiming to provide new insights and references for their safe application and further studies. Methods: A comprehensive search was conducted in PubMed, Google Scholar, Web of Science, and CNKI for peer-reviewed research articles and reviews published in the past 15 years. The research progress of the five major rhubarb AQs and the applications of cutting-edge technologies in their toxicity studies were summarized. Results: The toxicities of AQs mainly target the liver, kidney, heart, reproductive system, and nervous system. Their toxic mechanisms involve multiple pathways, including mitochondrial apoptosis, oxidative stress, death receptor pathway, endoplasmic reticulum (ER)-related apoptosis, caspase-dependent apoptosis, autophagy, inflammation, DNA damage, and bilirubin metabolism. The in vivo metabolism of AQs is complicated, and both Phase I and Phase II metabolites are linked to toxicity. The diverse metabolites can interconvert and undergo various reactions in vivo, posing great challenges for toxicity research. In the future, the application of advanced technologies, such as multi-omics and single-cell sequencing, artificial intelligence (AI) and computer simulation, microfluidics, and mass spectrometry imaging (MSI) will provide strong support for accurately elucidating toxic mechanisms, enabling toxicity prediction, and optimizing detoxification strategies, and will become effective approaches to advance toxicity studies of rhubarb AQs. Conclusion: The intrinsic toxicity and complex metabolic processes of rhubarb AQs restrict their clinical application. Current studies on the toxic mechanisms, metabolism-toxicity relationships, and multifactorial regulation of AQs still require further in-depth investigation. Future research should focus on the metabolism-toxicity relationship, key toxic targets, and detoxification strategies of AQs, and establish an integrated toxicity research system combined with advanced technologies, so as to provide robust support for the safe application and clinical development of rhubarb AQs.

Indexed as

AnthraquinonesRheumAnimalsHumansAnthraquinonesmetabolismperspectivesrhubarb AQstoxicitytoxicity mechanism

Identifiers

PMID42170519
PMCPMC13187117

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.